Concepedia

Deborah Kuk

DK

64

Publications

7.9K

Citations

46

H-Index

2011

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Columbia University Irving Medical Center

University of California, San Francisco

Flatiron Health (United States)

Deborah Kuk is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2011–2023

64

Publications

64

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

Alexander C. Huang, Michael A. Postow, Robert J. Orlowski et al. · Nature · 2017 · 1.6K citations · Full text

, , +8

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma

Peter J. Allen, Deborah Kuk, Carlos Fernández-del Castillo et al. · Annals of Surgery · 2016 · 478 citations · Full text

Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma

Marcus Tan, Murray F. Brennan, Deborah Kuk et al. · Annals of Surgery · 2015 · 356 citations

Integrated NY-ESO-1 antibody and CD8<sup>+</sup>T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

Jianda Yuan, Matthew Adamow, Brian Ginsberg et al. · Proceedings of the National Academy of Sciences · 2011 · 325 citations

The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma

Alexander N. Shoushtari, Rodrigo Ramella Munhoz, Deborah Kuk et al. · Cancer · 2016 · 298 citations · Full text

Rows per page

1–5 of 64